26 May 2013
Keywords: elan, biogen, initiate, phase, iii, trial, antegren
Article | 07 January 2002
Ireland's Elan Corp and USA-based Biogen say they have "enrolled anddosed" the first patients in their Phase III trials of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 January 2002
24 May 2013
© 2013 thepharmaletter.com